A critical discovery in cancer investigation is arising with the use of nanobodies to re-engage mutated p53. This vital cancer inhibitor protein is frequently disabled in various types of tumors, leading uncontrolled https://tornadosocial.com/story7637966/mini-antibodies-revive-the-p53-protein-a-new-hope-for-tumor-management